MedTrace Logo

Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers

NCT01924234 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2014-12-03

No results posted yet for this study

Summary

The purpose of the study is to determine whether remifentanil influence the pharyngeal phase of swallowing using using pressure and impedance recordings. The purpose is also to compare remifentanil to morphine and younger to elderly volunteers.

Conditions

  • Pharyngeal Dysfunction
  • Pharyngeal Swallowing

Interventions

DRUG

Morphine

DRUG

Remifentanil

Sponsors & Collaborators

  • Region Örebro County

    lead OTHER

Principal Investigators

  • Johanna Savilampi, M.D · Department of Anesthesiology and Intensive Care, Örebro University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01924234 on ClinicalTrials.gov